Beck Bode, LLC Checkpoint Therapeutics, Inc. Transaction History

Beck Bode, LLC

  • $529 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

Nov 27, 2019
SELL
$2.01 - $4.01 $20,099 - $40,100
-10,000 Closed
0 $0
Q4 2018

Nov 27, 2019
BUY
$1.54 - $3.35 $15,400 - $33,500
10,000 New
10,000 $18,000

Others Institutions Holding CKPT

# of Institutions
3
Shares Held
1.91M
Call Options Held
0
Put Options Held
0
View Full List

About Checkpoint Therapeutics, Inc.

CKPT Quotes by TradingView
  • Ticker CKPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 85,497,000
  • Market Cap $304M
  • Description
  • Checkpoint Therapeutics, Inc., clinical-stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. The company's lead antibody product candidate is Cosibelimab, a fully-human monoclonal antibody of IgG1 subtype that directly binds to...
More about CKPT
Track This Portfolio

Track Beck Bode, LLC Portfolio

Follow Beck Bode, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beck Bode, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beck Bode, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email